QUANTECH PARTNERS LTD
Company number 13155867 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
QUANTECH PARTNERS LTD - Analysis Report
Company Number: 13155867
Analysis Date: 2025-07-29 12:42 UTC
Financial Health Assessment for Quantech Partners Ltd (As of 31 January 2024)
1. Financial Health Score: B-
Explanation:
Quantech Partners Ltd shows a notable recovery from the previous years' negative financial position, moving into positive net assets territory by January 2024. The company is currently solvent with positive working capital and net assets, but the scale of assets and capital remains modest due to its micro-entity status. While the trend is positive, the relatively low asset base and small shareholder funds suggest cautious optimism rather than robust financial health.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Net Assets / Shareholders Funds | £2,064 | Positive net assets indicate solvency; the company has more assets than liabilities. |
| Net Current Assets (Working Capital) | £1,661 | Positive working capital signals the company can cover short-term obligations — a healthy cash flow symptom. |
| Fixed Assets | £903 | Small but increasing investment in long-term assets shows some asset base development. |
| Current Assets | £16,589 | Mainly cash or receivables — healthy liquidity to meet immediate expenses. |
| Current Liabilities | £15,203 | Manageable short-term debts; must be monitored to ensure timely repayment. |
| Share Capital | £10 | Nominal share capital typical for micro companies; equity mostly accumulated through retained earnings or capital injections. |
| Trend (2022-24) | Net assets improved from -£4,926 to +£2,064 | Indicates successful turnaround or restructuring efforts. |
3. Diagnosis
Quantech Partners Ltd experienced financial distress in its early years (2021-2023), evidenced by persistent negative net assets and negative working capital — classic "symptoms of distress" such as inability to cover current liabilities with current assets. This condition is akin to a patient showing signs of weakness and vulnerability.
However, by January 2024, there is a clear "recovery phase" with positive net current assets and net equity, indicating the business has strengthened its financial position and is now "standing on healthier feet." The company’s ability to maintain positive working capital and net assets suggests it is managing its short-term obligations efficiently and has overcome previous liquidity challenges.
Despite this recovery, the overall scale remains small, and the company's financial "vital signs" must be monitored closely to avoid relapse. The modest fixed asset base and micro-entity status imply limited capacity for sudden expansion or absorbing shocks without external support or operational improvements.
4. Recommendations
- Maintain Healthy Cash Flow: Continue to monitor and optimize the cash conversion cycle to ensure current assets exceed current liabilities, preserving liquidity.
- Build Equity Base: Consider strategic reinvestment of profits to strengthen shareholders’ funds, which acts like the company’s "financial immune system."
- Control Liabilities: Keep close watch on short-term debts and accruals to avoid over-extension, which can cause financial "stress symptoms" like cash shortages.
- Explore Growth Opportunities Carefully: With limited fixed assets and capital, growth should be measured and aligned with cash generation capacity to avoid over-leverage.
- Regular Financial Monitoring: Implement monthly or quarterly internal financial reviews to catch early signs of distress, akin to routine health check-ups.
- Engage Professional Advice: If planning expansion or significant changes, seek expert financial or strategic advice to ensure sustainable growth.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.